|
1
|
Thom T, Haase N, Rosamond W, et al;
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee. Heart disease and stroke statistics - 2006
update: a report from the American Heart Association Statistics
Committee and Stroke Statistics Subcommittee. Circulation.
113:e85–e151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nabel EG and Braunwald E: A tale of
coronary artery disease and myocardial infarction. N Engl J Med.
366:54–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mathers CD and Loncar D: Projections of
global mortality and burden of disease from 2002 to 2030. PLoS Med.
3:e4222006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lloyd-Jones D, Adams RJ, Brown TM, et al;
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee. Heart disease and stroke statistics - 2010
update: a report from the American Heart Association. Circulation.
121:e46–e215. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Renda G and de Caterina R: Impact of
antiplatelet therapy in heart disease. Adv Cardiol. 47:5–19. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gnecchi M, Danieli P and Cervio E:
Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol.
57:48–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Songco AV and Brener SJ: Initial strategy
of revascularization versus optimal medical therapy for improving
outcomes in ischemic heart disease: a review of the literature.
Curr Cardiol Rep. 14:397–407. 2012. View Article : Google Scholar
|
|
8
|
Bhind R, Witting PK, McMahon AC,
Khachigian LM and Lowe HC: Rat models of myocardial infarction.
Pathogenetic insights and clinical relevance. Thromb Haemost.
96:602–610. 2006.PubMed/NCBI
|
|
9
|
Langendorff O: Untersuchungen am
überlebenden Säugethierherzen. Arch Ges Physiol. 61:291–332.
1895.
|
|
10
|
Skrzypiec-Spring M, Grotthus B, Szelag A
and Schulz R: Isolated heart perfusion according to Langendorff -
still viable in the new millennium. J Pharmacol Toxicol Methods.
55:113–126. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang R: Two’s company, three’s a crowd:
can H2S be the third endogenous gaseous transmitter?
FASEB J. 16:1792–1798. 2002.
|
|
12
|
Ignarro LJ, Buga GM, Wood KS, Byrns RE and
Chaudhuri G: Endothelium-derived relaxing factor produced and
released from artery and vein is nitric oxide. Proc Natl Acad Sci
USA. 84:9265–9269. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Palmer RM, Ferrige AG and Moncada S:
Nitric oxide release accounts for the biological activity of
endothelium derived relaxing factor. Nature. 327:524–526. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marks GS, Brien JF, Nakatsu K, et al: Does
carbon monoxide have a physiological function? Trends Pharmacol
Sci. 12:185–188. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Verma A, Hirsch DJ, Glatt CE, et al:
Carbon monoxide: a putative neural messenger. Science. 259:381–384.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abe K and Kimura H: The possible role of
hydrogen sulfide as an endogenous neuromodulator. J Neurosci.
16:1066–1071. 1996.PubMed/NCBI
|
|
17
|
Pearson RJ, Wilson T and Wang R:
Endogenous hydrogen sulfide and the cardiovascular system-what’s
the smell all about? Clin Invest Med. 29:146–150. 2006.
|
|
18
|
Szabó C: Hydrogen sulphide and its
therapeutic potential. Nat Rev Drug Discov. 6:917–935. 2007.
|
|
19
|
Jha S, Calvert JW, Duranski MR,
Ramachandran A and Lefer DJ: Hydrogen sulfide attenuates hepatic
ischemia-reperfusion injury: role of antioxidant and antiapoptotic
signaling. Am J Physiol Heart Circ Physiol. 295:H801–H806. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bos EM, Leuvenink HG, Snijder PM, et al:
Hydrogen sulfide-induced hypometabolism prevents renal
ischemia/reperfusion injury. J Am Soc Nephrol. 20:1901–1905. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang MJ, Cai WJ, Li N, Ding YJ, Chen Y and
Zhu YC: The hydrogen sulfide donor NaHS promotes angiogenesis in a
rat model of hind limb ischemia. Antioxid Redox Signal.
12:1065–1077. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Huang H, Liu P, Tang C and Wang
J: Hydrogen sulfide contributes to cardioprotection during
ischemia-reperfusion injury by opening K ATP channels. Can J
Physiol Pharmacol. 85:1248–1253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ji Y, Pang QF, Xu G, Wang L, Wang JK and
Zeng YM: Exogenous hydrogen sulfide postconditioning protects
isolated rat hearts against ischemia-reperfusion injury. Eur J
Pharmacol. 587:1–7. 2008. View Article : Google Scholar
|
|
24
|
Sodha NR, Clements RT, Feng J, et al: The
effects of therapeutic sulfide on myocardial apoptosis in response
to ischemia-reperfusion injury. Eur J Cardiothorac Surg.
33:906–913. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sivarajah A, Collino M, Yasin M, et al:
Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in
a rat model of regional myocardial I/R. Shock. 31:267–274. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lavu M, Bhushan S and Lefer DJ: Hydrogen
sulfide-mediated cardioprotection: mechanisms and therapeutic
potential. Clin Sci (Lond). 120:219–229. 2011.PubMed/NCBI
|
|
27
|
Liu H, Yan J, Xu YW, Bai XJ and Wu BW:
Modification of ex-vivo ischemia/reperfusion modeling in isolated
rat heart. Chinese Remedies & Clinics. 7:586–587. 2007.(In
Chinese).
|
|
28
|
Stipanuk MH and Beck PW: Characterization
of the enzymic capacity for cysteine desulphhydration in liver and
kidney of the rat. Biochem J. 206:267–277. 1982.PubMed/NCBI
|
|
29
|
Hwa JS, Jin YC, Lee YS, et al:
2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat
myocardial ischemia and reperfusion injury in vivo due to HO-1
induction. J Ethnopharmacol. 139:605–615. 2012.
|
|
30
|
Shiva S, Brookes PS and Darley-Usmar VM:
Methods for measuring the regulation of respiration by nitric
oxide. Methods Cell Biol. 80:395–416. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Abe K and Kimura H: The possible role of
hydrogen sulfide as an endogenous neuromodulator. J Neurosci.
16:1066–1071. 1996.PubMed/NCBI
|
|
32
|
Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J
and Tang C: H2S generated by heart in rat and its
effects on cardiac function. Biochem Biophys Res Commun.
313:362–368. 2004.
|
|
33
|
Li L, Rose P and Moore PK: Hydrogen
sulfide and cell signaling. Annu Rev Pharmacol Toxicol. 51:169–187.
2011. View Article : Google Scholar
|
|
34
|
Chen P, Poddar R, Tipa EV, et al:
Homocysteine metabolism in cardiovascular cells and tissues:
implications for hyperhomocysteinemia and cardiovascular disease.
Adv Enzyme Regul. 39:93–109. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Szabó C: Hydrogen sulphide and its
therapeutic potential. Nat Rev Drug Discov. 6:917–935. 2007.
|
|
36
|
Zhao W, Zhang J, Lu Y and Wang R: The
vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP)
channel opener. EMBO J. 20:6008–6016. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Geng B, Chang L, Pan C, et al: Endogenous
hydrogen sulfide regulation of myocardial injury induced by
isoproterenol. Biochem Biophys Res Commun. 318:756–763. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang HL, Wu HC, Li ZL, Geng B and Tang
CS: Changes of the new gaseous transmitter H2S in
patients with coronary heart disease. Di Yi Jun Yi Da Xue Xue Bao.
25:951–954. 2005.(In Chinese).
|
|
39
|
Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY,
Zhou S and Moore PK: Role of hydrogen sulfide in the
cardioprotection caused by ischemic preconditioning in the rat
heart and cardiac myocytes. J Pharmacol Exp Ther. 316:670–678.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yong QC, Pan TT, Hu LF and Bian JS:
Negative regulation of beta-adrenergic function by hydrogen
sulphide in the rat hearts. J Mol Cell Cardiol. 44:701–710. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tokuda K, Kida K, Marutani E, et al:
Inhaled hydrogen sulfide prevents endotoxin-induced systemic
inflammation and improves survival by altering sulfide metabolism
in mice. Antioxid Redox Signal. 17:11–21. 2012. View Article : Google Scholar
|
|
42
|
Jiang LH, Luo X, He WA, Huang XX and Cheng
TT: Effects of exogenous hydrogen sulfide on apoptosis proteins and
oxidative stress in the hippocampus of rats undergoing heroin
withdrawal. Arch Pharm Res. 34:2155–2162. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ytrehus K: The ischemic heart -
experimental models. Pharmacol Res. 42:193–203. 2000. View Article : Google Scholar
|
|
44
|
Kelly PJ, Kistler JP, Shih VE, et al:
Inflammation, homocysteine, and vitamin B6 status after ischemic
stroke. Stroke. 35:12–15. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Diwakar L and Ravindranath V: Inhibition
of cystathionine-gamma-lyase leads to loss of glutathione and
aggravation of mitochondrial dysfunction mediated by excitatory
amino acid in the CNS. Neurochem Int. 50:418–426. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Blaustein A, Deneke SM, Stolz RI, Baxter
D, Healey N and Fanburg BL: Myocardial glutathione depletion
impairs recovery after short periods of ischemia. Circulation.
80:1449–1457. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dombkowski RA, Russell MJ and Olson KR:
Hydrogen sulfide as an endogenous regulator of vascular smooth
muscle tone in trout. Am J Physiol Regul Integr Comp Physiol.
286:R678–R685. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY,
Zhou S and Moore PK: Role of hydrogen sulfide in the
cardioprotection caused by ischemic preconditioning in the rat
heart and cardiac myocytes. J Pharmacol Exp Ther. 316:670–678.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hosoki R, Matsuki N and Kimura H: The
possible role of hydrogen sulfide as an endogenous smooth muscle
relaxant in synergy with nitric oxide. Biochem Biophys Res Commun.
237:527–531. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nie LH, Zhou YZ, Ding J, et al: Effects of
matrine on infarct size and ultramicrostructure in rats with acute
myocardial ischemic injury. Ningxia Med J. 33:292–294. 2011.(In
Chinese).
|
|
51
|
Yang GD, Wu LY, Jiang B, et al:
H2S as a physiologic vasorelaxant: hypertension in mice
with deletion of cystathionine gamma-lyase. Science. 322:587–590.
2008.
|
|
52
|
Wang R: Hydrogen sulfide: a new EDRF.
Kidney Int. 76:700–704. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Murry CE, Richard VJ, Reimer KA and
Jennings RB: Ischemic preconditioning slows energy metabolism and
delays ultrastructural damage during a sustained ischemic episode.
Circ Res. 66:913–931. 1990. View Article : Google Scholar
|
|
54
|
Flameng W, Andres J, Ferdinande P,
Mattheussen M and Van Belle H: Mitochondrial function in myocardial
stunning. J Mol Cell Cardiol. 23:1–11. 1991. View Article : Google Scholar
|
|
55
|
Lesnefsky EJ, Tandler B, Ye J, Slabe TJ,
Turkaly J and Hoppel CL: Myocardial ischemia decreases oxidative
phosphorylation through cytochrome oxidase in subsarcolemmal
mitochondria. Am J Physiol. 273:H1544–H1554. 1997.
|
|
56
|
Lesnefsky EJ, Moghaddas S, Tandler B,
Kerner J and Hoppel CL: Mitochondrial dysfunction in cardiac
disease: ischemia - reperfusion, aging, and heart failure. J Mol
Cell Cardiol. 33:1065–1089. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lowell BB and Shulman GI: Mitochondrial
dysfunction and type 2 diabetes. Science. 307:384–387. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Roden M: Muscle triglycerides and
mitochondrial function: possible mechanisms for the development of
type 2 diabetes. Int J Obes (Lond). 29(Suppl 2): S111–S115. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hardy L, Clark JB, Darley-Usmar VM, Smith
DR and Stone D: Reoxygenation-dependent decrease in mitochondrial
NADH:CoQ reductase (Complex I) activity in the hypoxic/reoxygenated
rat heart. Biochem J. 274:133–137. 1991.PubMed/NCBI
|
|
60
|
Liu F, Zhang JX, Li LF, Zhang QZ, Ding YY
and Zhang XY: Effects of hydrogen sulfide on myocardial
mitochondrial injury during acute myocardial ischemia in rats.
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 27:158–162. 2011.(In
Chinese).
|
|
61
|
Crystal GJ, Malik G, Yoon SH and Kim SJ:
Isoflurane late preconditioning against myocardial stunning is
associated with enhanced antioxidant defenses. Acta Anaesthesiol
Scand. 56:39–47. 2012. View Article : Google Scholar
|
